UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates
Provided By GlobeNewswire
Last update: Aug 6, 2024
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the second quarter ended June 30, 2024.
Read more at globenewswire.com
